Study Stopped
COVID-19 pandemic
Same-day Discharge After Reconstructive Pelvic Surgery
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The purpose of this study is to determine the safety and acceptability of same-day discharge after surgery for pelvic floor disorders. The study hypotheses are that same-day discharge after reconstructive pelvic surgery is safe and improves patient satisfaction when compared to overnight hospitalization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2020
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2019
CompletedFirst Posted
Study publicly available on registry
October 17, 2019
CompletedStudy Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedApril 26, 2021
April 1, 2021
2.3 years
October 10, 2019
April 22, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Quality of Recovery Score
Quality of recovery will be assessed using the Quality of Recovery-15 (QoR-15) at baseline, 48 hours postop, and 6-8 weeks postop. The QoR-15 consists of 15 questions scored on a 0 to 10 scale, maximum score 150. Higher scores indicate good recovery after surgery while lower scores indicate poor recovery.
6 to 8 weeks after surgery
Patient Satisfaction
Patient satisfaction will be assessed using the Patient Global Impression of Improvement (PGI-I) at 6-8 weeks postop. The PGI-I consists of 1 question scored 1-7, with lower number indicating better global improvement.
6 to 8 weeks after surgery
Secondary Outcomes (8)
Safety Measures: frequency of post operative complications
Up to 8 weeks after surgery
Quality of Recovery (baseline)
Baseline
Quality of Recovery (48 hours)
48 hours postop
Quality of Recovery (at postop visit)
48 hours postop
Pelvic Floor Distress (baseline)
Baseline
- +3 more secondary outcomes
Study Arms (2)
SDD
ACTIVE COMPARATORPatients will receive routine care during their admission for surgery. A standard voiding trial will be performed in the PACU for all patients. Patients in the planned same day discharge (SDD) cohort will be discharged from the PACU once they meet standard discharge criteria.
OH
ACTIVE COMPARATORPatients will receive routine care during their admission for surgery. A standard voiding trial will be performed in the PACU for all patients. Patients in the planned overnight hospitalization (OH) group will be discharged on post-operative day 1 once they meet standard discharge criteria.
Interventions
Patients in the planned same day discharge (SDD) cohort will be discharged from the PACU once they meet standard discharge criteria.
Patients in the planned overnight hospitalization (OH) group will be discharged on post-operative day 1 once they meet standard discharge criteria.
Eligibility Criteria
You may qualify if:
- Patients undergoing surgery for pelvic organ prolapse, with or without concomitant hysterectomy or incontinence procedure.
You may not qualify if:
- Patients undergoing concomitant non-gynecologic procedure
- The presence of: gynecologic malignancy, American Society of Anesthesiologists (ASA) class \>2, severe cardiovascular or pulmonary comorbidities, prior anesthesia complication, or obstructive sleep apnea
- Anyone living alone with no family/friend/caretaker to assist the patient on day of surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
Study Officials
- PRINCIPAL INVESTIGATOR
Oz Harmanli, MD
Chief, Yale Urogynecology and Pelvic Reconstructive Surgery
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2019
First Posted
October 17, 2019
Study Start
July 1, 2020
Primary Completion
October 31, 2022
Study Completion
April 30, 2023
Last Updated
April 26, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share